Cargando…

The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor

INTRODUCTION: Idiopathic pulmonary fibrosis (IPF) is a progressive and irreversible fibrotic lung disease, resulting in respiratory insufficiency and reduced survival. Pulmonary fibrosis is a result of repeated alveolar epithelial microinjuries, followed by abnormal regeneration and repair processes...

Descripción completa

Detalles Bibliográficos
Autores principales: Gazdhar, Amiq, Grad, Iwona, Tamò, Luca, Gugger, Mathias, Feki, Anis, Geiser, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445988/
https://www.ncbi.nlm.nih.gov/pubmed/25384638
http://dx.doi.org/10.1186/scrt513
_version_ 1782373354123034624
author Gazdhar, Amiq
Grad, Iwona
Tamò, Luca
Gugger, Mathias
Feki, Anis
Geiser, Thomas
author_facet Gazdhar, Amiq
Grad, Iwona
Tamò, Luca
Gugger, Mathias
Feki, Anis
Geiser, Thomas
author_sort Gazdhar, Amiq
collection PubMed
description INTRODUCTION: Idiopathic pulmonary fibrosis (IPF) is a progressive and irreversible fibrotic lung disease, resulting in respiratory insufficiency and reduced survival. Pulmonary fibrosis is a result of repeated alveolar epithelial microinjuries, followed by abnormal regeneration and repair processes in the lung. Recently, stem cells and their secretome have been investigated as a novel therapeutic approach in pulmonary fibrosis. We evaluated the potential of induced pluripotent stem cells (iPSC) conditioned media (iPSC-cm) to regenerate and repair the alveolar epithelium in vitro and improve bleomycin induced lung injury in vivo. METHODS: IPSC-cm was collected from cultured iPSC derived from human foreskin fibroblasts and its biological effects on alveolar epithelial wound repair was studied in an alveolar wound healing assay in vitro. Furthermore, iPSC-cm was intratracheally instilled 7 days after bleomycin induced injury in the rat lungs and histologically and biochemically assessed 7 days after instillation. RESULTS: iPSC-cm increased alveolar epithelial wound repair in vitro compared with medium control. Intratracheal instillation of iPSC-cm in bleomycin-injured lungs reduced the collagen content and improved lung fibrosis in the rat lung in vivo. Profibrotic TGFbeta1 and α-smooth muscle actin (α-sma) expression were markedly reduced in the iPSC-cm treated group compared with control. Antifibrotic hepatocyte growth factor (HGF) was detected in iPSC-cm in biologically relevant levels, and specific inhibition of HGF in iPSC-cm attenuated the antifibrotic effect of iPSC-cm, indicating a central role of HGF in iPSC-cm. CONCLUSION: iPSC-cm increased alveolar epithelial wound repair in vitro and attenuated bleomycin induced fibrosis in vivo, partially due to the presence of HGF and may represent a promising novel, cell free therapeutic option against lung injury and fibrosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/scrt513) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4445988
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44459882015-05-28 The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor Gazdhar, Amiq Grad, Iwona Tamò, Luca Gugger, Mathias Feki, Anis Geiser, Thomas Stem Cell Res Ther Research INTRODUCTION: Idiopathic pulmonary fibrosis (IPF) is a progressive and irreversible fibrotic lung disease, resulting in respiratory insufficiency and reduced survival. Pulmonary fibrosis is a result of repeated alveolar epithelial microinjuries, followed by abnormal regeneration and repair processes in the lung. Recently, stem cells and their secretome have been investigated as a novel therapeutic approach in pulmonary fibrosis. We evaluated the potential of induced pluripotent stem cells (iPSC) conditioned media (iPSC-cm) to regenerate and repair the alveolar epithelium in vitro and improve bleomycin induced lung injury in vivo. METHODS: IPSC-cm was collected from cultured iPSC derived from human foreskin fibroblasts and its biological effects on alveolar epithelial wound repair was studied in an alveolar wound healing assay in vitro. Furthermore, iPSC-cm was intratracheally instilled 7 days after bleomycin induced injury in the rat lungs and histologically and biochemically assessed 7 days after instillation. RESULTS: iPSC-cm increased alveolar epithelial wound repair in vitro compared with medium control. Intratracheal instillation of iPSC-cm in bleomycin-injured lungs reduced the collagen content and improved lung fibrosis in the rat lung in vivo. Profibrotic TGFbeta1 and α-smooth muscle actin (α-sma) expression were markedly reduced in the iPSC-cm treated group compared with control. Antifibrotic hepatocyte growth factor (HGF) was detected in iPSC-cm in biologically relevant levels, and specific inhibition of HGF in iPSC-cm attenuated the antifibrotic effect of iPSC-cm, indicating a central role of HGF in iPSC-cm. CONCLUSION: iPSC-cm increased alveolar epithelial wound repair in vitro and attenuated bleomycin induced fibrosis in vivo, partially due to the presence of HGF and may represent a promising novel, cell free therapeutic option against lung injury and fibrosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/scrt513) contains supplementary material, which is available to authorized users. BioMed Central 2014-11-10 /pmc/articles/PMC4445988/ /pubmed/25384638 http://dx.doi.org/10.1186/scrt513 Text en © Gazdhar et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Gazdhar, Amiq
Grad, Iwona
Tamò, Luca
Gugger, Mathias
Feki, Anis
Geiser, Thomas
The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor
title The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor
title_full The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor
title_fullStr The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor
title_full_unstemmed The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor
title_short The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor
title_sort secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445988/
https://www.ncbi.nlm.nih.gov/pubmed/25384638
http://dx.doi.org/10.1186/scrt513
work_keys_str_mv AT gazdharamiq thesecretomeofinducedpluripotentstemcellsreduceslungfibrosisinpartbyhepatocytegrowthfactor
AT gradiwona thesecretomeofinducedpluripotentstemcellsreduceslungfibrosisinpartbyhepatocytegrowthfactor
AT tamoluca thesecretomeofinducedpluripotentstemcellsreduceslungfibrosisinpartbyhepatocytegrowthfactor
AT guggermathias thesecretomeofinducedpluripotentstemcellsreduceslungfibrosisinpartbyhepatocytegrowthfactor
AT fekianis thesecretomeofinducedpluripotentstemcellsreduceslungfibrosisinpartbyhepatocytegrowthfactor
AT geiserthomas thesecretomeofinducedpluripotentstemcellsreduceslungfibrosisinpartbyhepatocytegrowthfactor
AT gazdharamiq secretomeofinducedpluripotentstemcellsreduceslungfibrosisinpartbyhepatocytegrowthfactor
AT gradiwona secretomeofinducedpluripotentstemcellsreduceslungfibrosisinpartbyhepatocytegrowthfactor
AT tamoluca secretomeofinducedpluripotentstemcellsreduceslungfibrosisinpartbyhepatocytegrowthfactor
AT guggermathias secretomeofinducedpluripotentstemcellsreduceslungfibrosisinpartbyhepatocytegrowthfactor
AT fekianis secretomeofinducedpluripotentstemcellsreduceslungfibrosisinpartbyhepatocytegrowthfactor
AT geiserthomas secretomeofinducedpluripotentstemcellsreduceslungfibrosisinpartbyhepatocytegrowthfactor